RE: Also from the RNS...7 Jul 2018 09:08
What an interesting perspective, Piltick, but I'm finding it nigh on impossible to find examples of companies across all sectors refusing to publish updated data for fear of potential competitors, let alone actual competitors: take pharmaceuticals, for example, where actual competitors abound, trial results are constantly released on novel formulations.
Unlike yourself, my conclusion is that even basic longevity milestones have singularly failed to be attained, and that a 365 days a year operational system is but an unrealisable concept. Do you not find it surprising that after discussions and sharing data with multiple alledged national and international companies not one has placed a firm order nor licensed the unpatented technology?
I'm sure that you won't raise the "copyright" on "DMG" as a redeeming feature as any potential competitor would just call the process by a different term.
.
.